Tilray Brands Inc. (TLRY)
Tilray Medical veröffentlicht bahnbrechende Forschungsergebnisse zur Pharmakokinetik von THC- und CBD-Formulierungen
Tilray Brands Inc. (TLRY)
Tilray Medical publie une recherche pionnière sur la pharmacocinétique des formulations de THC et de CBD
Kymera Therapeutics Inc (KYMR)
Kymera Therapeutics Announces Pricing of $250 Million Public Offering
Achieve Life Sciences Inc. (ACHV)
Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering
Aoxin Q & M Dental Grp Limited (1D4)
Q & M Dental Group (Singapore) Limited - Announcement
Bristol-Myers Squibb Company (BMY)
Bristol Myers Squibb - U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb’s Cell Therapy Labels
Bristol-Myers Squibb Co. (BMYMP)
U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb’s Cell Therapy Labels
Bristol-Myers Squibb Company (BMY)
U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb’s Cell Therapy Labels
Evofem Biosciences, Inc. (EVFM)
Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem’s Hormone-Free, On-Demand Prescription Contraceptive Gel
MustGrow Biologics Corporation (MGROF)
MustGrow Biologics Corp. Announces Results of Shareholder Meeting